News Detail
New Delhi, 11 Oct 2022: The Indian Patent Office (IPO) has granted a patent application submitted by the National Institute of Pharmaceutical Education and Research (NIPER), Mohali, for the rights of a compound as anti-tubercular agents and an improved process for its preparation......
View Details
Source : Pharmabiz
Indian Patent Office
IPO
NIPER
anti-tubercular
Novel 2-(2'-Aminophenyl)
benzazoles
tuberculosis
human immunodeficiency virus
HIV. DOTS
MDR-TB
XDR-TB
benzoxazole
benzthizoles
Global TB Report 2021
Related News
- Researchers develop a better way to deliver long-lasting drugs (25-03-2025)
- Pioneer groundbreaking light-driven method to create key drug compounds (24-03-2025)
- Mandimycin: A polyene antifungal with a unique mode of action (22-03-2025)
- Newly identified bacterial protein helps design cancer drug delivery system (21-03-2025)
- IIT Roorkee researchers identify a potential drug against Chikungunya (18-03-2025)
- New test enables doctors to anticipate a serious side effect of cancer therapy (17-03-2025)
- Chinese vaccine shows promise in stopping plaque build-up in arteries (15-03-2025)
- Researchers develop technique for storing life-saving drugs without temperature control (15-03-2025)
- NIT researchers develop eco-friendly process to remove pharmaceutical pollutants from wastewater (14-03-2025)
- New personalised vaccine shows promise in treating deadly pancreatic cancer (13-03-2025)